Proteomics and Opportunities for Clinical Translation in Urological Disease

Journal of Urology

Volumn 182, Issue 3, 2009, Pages 835-843

  Vaezzadeh, Ali R ^a   Steen, Hanno ^a   Freeman, Michael R ^a   Lee, Richard S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

biological markers; chromatography; liquid; mass spectrometry; proteomics

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL MEDICINE; ELECTROSPRAY MASS SPECTROMETRY; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL LITERATURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINARY TRACT DISEASE;

BIOLOGICAL MARKERS; HUMANS; PROTEOMICS; URINALYSIS; URINE; UROLOGIC DISEASES;

EID: 68149100805     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.05.001     Document Type: Review

References (55)

1. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198
2. Pennisi E. Genetics. Working the (gene count) numbers: finally, a firm answer?. Science 316 (2007) 1113
3. Kelleher N.L. Top-down proteomics. Anal Chem 76 (2004) 197A
4. Link A.J., Eng J., Schieltz D.M., et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17 (1999) 676
5. Fenn J.B., Mann M., Meng C.K., et al. Electrospray ionization for mass spectrometry of large biomolecules. Science 246 (1989) 64
6. Karas M., and Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60 (1988) 2299
7. Bodnar W.M., Blackburn R.K., Krise J.M., et al. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J Am Soc Mass Spectrom 14 (2003) 971
8. Glish G.L., and Burinsky D.J. Hybrid mass spectrometers for tandem mass spectrometry. J Am Soc Mass Spectrom 19 (2008) 161
9. Poon T.C. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 4 (2007) 51
10. Issaq H., and Veenstra T. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives. Biotechniques 44 (2008) 697
11. Pappin D.J., Hojrup P., and Bleasby A.J. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3 (1993) 327
12. Hernandez P., Muller M., and Appel R.D. Automated protein identification by tandem mass spectrometry: issues and strategies. Mass Spectrom Rev 25 (2006) 235
13. Nesvizhskii A.I., and Aebersold R. Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics 4 (2005) 1419
14. Ong S.E., Blagoev B., Kratchmarova I., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1 (2002) 376
15. Gygi S.P., Rist B., Gerber S.A., et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17 (1999) 994
16. Ross P.L., Huang Y.N., Marchese J.N., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3 (2004) 1154
17. Yao X., Afonso C., and Fenselau C. Dissection of proteolytic 18O labeling: endoprotease-catalyzed 16O-to-18O exchange of truncated peptide substrates. J Proteome Res 2 (2003) 147
18. Old W.M., Meyer-Arendt K., Aveline-Wolf L., et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 4 (2005) 1487
19. Gerber S.A., Rush J., Stemman O., et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 100 (2003) 6940
20. Collins M.O., Yu L., and Choudhary J.S. Analysis of protein phosphorylation on a proteome-scale. Proteomics 7 (2007) 2751
21. Temporini C., Calleri E., Massolini G., et al. Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins. Mass Spectrom Rev 27 (2008) 207
22. Orchard S., Hermjakob H., Julian Jr. R.K., et al. Common interchange standards for proteomics data: public availability of tools and schema. Proteomics 4 (2004) 490
23. Lescuyer P., Hochstrasser D., and Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery?. J Proteome Res 6 (2007) 3371
24. Howard B.A., Wang M.Z., Campa M.J., et al. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics 3 (2003) 1720
25. Anderson L., and Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5 (2006) 573
26. Yamamoto T., Langham R.G., Ronco P., et al. Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA. Proteomics 8 (2008) 2156
27. Lee R.S., Monigatti F., Briscoe A.C., et al. Optimizing sample handling for urinary proteomics. J Proteome Res 7 (2008) 4022
28. Thongboonkerd V. Practical points in urinary proteomics. J Proteome Res 6 (2007) 3881
29. Spahr C.S., Davis M.T., McGinley M.D., et al. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics 1 (2001) 93
30. Castagna A., Cecconi D., Sennels L., et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res 4 (2005) 1917
31. Adachi J., Kumar C., Zhang Y., et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 7 (2006) R80
32. Sun W., Li F., Wu S., et al. Human urine proteome analysis by three separation approaches. Proteomics 5 (2005) 4994
33. Lee R.S., Monigatti F., Lutchman M., et al. Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation. Proteomics 8 (2008) 1097
34. O'Riordan E., Orlova T.N., Podust V.N., et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant 7 (2007) 930
35. Clarke W., Silverman B.C., Zhang Z., et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 237 (2003) 660
36. Haubitz M., Wittke S., Weissinger E.M., et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 67 (2005) 2313
37. Schiffer E., Mischak H., and Novak J. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 6 (2006) 5615
38. Weissinger E.M., Wittke S., Kaiser T., et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 65 (2004) 2426
39. Decramer S., Wittke S., Mischak H., et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 12 (2006) 398
40. Rogers M.A., Clarke P., Noble J., et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 63 (2003) 6971
41. Theodorescu D. Cryotherapy for prostate cancer: what we know, what we need to know. J Urol 180 (2008) 437
42. Smalley D.M., Sheman N.E., Nelson K., et al. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res 7 (2008) 2088
43. Saito M., Kimoto M., Araki T., et al. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers. Eur Urol 48 (2005) 865
44. Irmak S., Tilki D., Heukeshoven J., et al. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics 5 (2005) 4296
45. Celis J.E., Gromova I., Moreira J.M., et al. Impact of proteomics on bladder cancer research. Pharmacogenomics 5 (2004) 381
46. Orenes-Pinero E., Corton M., Gonzalez-Peramato P., et al. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res 6 (2007) 4440
47. Langbein S., Lehmann J., Harder A., et al. Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol Cancer Res Treat 5 (2006) 67
48. McDonnell L.A., and Heeren R.M. Imaging mass spectrometry. Mass Spectrom Rev 26 (2007) 606
49. Xu B.J., Shyr Y., Liang X., et al. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol 16 (2005) 2967
50. Meistermann H., Norris J.L., Aerni H.R., et al. Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat. Mol Cell Proteomics 5 (2006) 1876
51. Chaurand P., Rahman M.A., Hunt T., et al. Monitoring mouse prostate development by profiling and imaging mass spectrometry. Mol Cell Proteomics 7 (2008) 411
52. Everley P.A., Krijgsveld J., Zetter B.R., et al. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics 3 (2004) 729
53. MacLellan D.L., Steen H., Adam R.M., et al. A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells. Proteomics 5 (2005) 4733
54. Han C.L., Chien C.W., Chen W.C., et al. A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal-dominant polycystic kidney disease. Mol Cell Proteomics 7 (2008) 1983
55. Xu D., Suenaga N., Edelmann M.J., et al. Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol Cell Proteomics 7 (2008) 2215